Overview
Breast and ovarian cancer are malignancies arising in the breast tissue and ovaries, respectively, representing significant causes of cancer-related morbidity and mortality in women worldwide. Research published in Women's Reproductive Health addresses multiple dimensions of these cancers, from genetic susceptibility to novel therapeutic approaches. The journal has examined variants of uncertain clinical significance in BRCA1, a gene critically associated with hereditary breast and ovarian cancer risk, through functional and structural analysis to clarify their pathogenic potential. Investigations into treatment innovations include the development of pH-sensitive nanomedicine platforms specifically designed for gynecological cancers, exploiting the acidic tumor microenvironment to improve drug delivery and therapeutic efficacy. Additionally, research has explored molecular mechanisms that regulate cancer cell behavior, including studies on proteins that influence metastasis through modulation of cell adhesion molecules. The journal's coverage reflects the multifaceted nature of breast and ovarian cancer research, spanning genetic risk assessment, targeted drug delivery systems, and cellular mechanisms underlying cancer progression. Understanding these diverse aspects is essential for advancing early detection strategies, refining risk stratification, and developing more effective, personalized treatment options for women affected by these diseases.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
pH-Sensitive Nanomedicine for Treating Gynaecological Cancers
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Adopting High Fat Diets for Fat Loss and Improving Brain Health.
Protective Effect of Fennel Oil on Cyclophosphamide Inhibited Spermatogenesis and Induced Oxidative Stress in Albino Rats.
How this research is being cited
The 5 articles above have been cited 26 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Matylda Szewczyk-Łagodzińska et al. · 2023 · Polymers
-
2023 · CPT Pharmacometrics & Systems Pharmacology
-
2023 · CPT: Pharmacometrics & Systems Pharmacology
-
2023 · Polymers
-
2022 · Dicle Üniversitesi Veteriner Fakültesi Dergisi
-
Sheikh Tanzina Haque et al. · 2022 · Journal of Pharmaceutical Investigation
-
H. M. El-Nigomy et al. · 2022 · Mansoura Journal of Biology
-
Saptadwipa Ganguly et al. · 2022 · Tumor Suppressor Par-4
A sample of recent works citing this journal's research on Breast and Ovarian Cancer, linking to each citing work.